| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.028 | 0.6 |